These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4769514)

  • 1. Hypocalcemia following bilateral nephrectomy.
    Cheigh JS; Rubin AL; Stenzel KH; Whitsell JC
    Urology; 1973 Aug; 2(2):121-4. PubMed ID: 4769514
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.
    Tsai WC; Peng YS; Chiu YL; Wu HY; Pai MF; Hsu SP; Yang JY; Tung KT; Chen HY
    Int Urol Nephrol; 2015 Jul; 47(7):1203-7. PubMed ID: 26025063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and phosphorus studies: interpretation of results and strategies for further testing.
    Burke MD
    Postgrad Med; 1980 Jul; 68(1):69-72. PubMed ID: 7393785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 25(OH)-vitamin D3 in hypocalcemic patients on chronic hemodialysis.
    Kronfol NO; Hersh WR; Barakat MM
    ASAIO Trans; 1987; 33(3):289-92. PubMed ID: 3675956
    [No Abstract]   [Full Text] [Related]  

  • 5. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
    Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
    [No Abstract]   [Full Text] [Related]  

  • 7. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes following parathyroidectomy in hemodialyzed patients.
    Berland Y; Charhon S; Olmer M; Meunier PJ
    Adv Exp Med Biol; 1984; 178():241-52. PubMed ID: 6507159
    [No Abstract]   [Full Text] [Related]  

  • 10. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute neonatal hypocalcemia with cardiomegaly in 2 children from a mother with hyperparathyroidism].
    Joly JB
    Arch Fr Pediatr; 1973 Dec; 30(10):1037-42. PubMed ID: 4276424
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism.
    Ge P; Liu S; Sheng X; Li S; Xu M; Jiang J; Chen S
    Head Neck; 2018 Feb; 40(2):324-329. PubMed ID: 28963816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia and hyperparathyroidism after renal transplantation.
    Apaydin S; Sariyar M; Erek E; Ataman R; Yiğitbaş R; Hamzaoğlu I; Serdengeçti K; Ulkü U
    Nephron; 1999; 81(3):364-5. PubMed ID: 10050101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory aids in the diagnosis of metabolic bone disease.
    Goldsmith RS
    Orthop Clin North Am; 1972 Nov; 3(3):545-60. PubMed ID: 4344932
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients.
    Ding Y; Wang H; Zou Q; Jin Y; Zhang Z; Huang J
    Int Urol Nephrol; 2018 Mar; 50(3):535-540. PubMed ID: 29196929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent severe hypercalcemia during maintenance hemodialysis.
    Johnson WJ
    Ann Intern Med; 1980 Aug; 93(2):272-5. PubMed ID: 7406379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
    Baker LR; Muir JW; Cattell WR; Tucker KA; Sharman VL; Goodwin FJ; Marsh FP; Hately W; Morgan AG; de Saintonge DM
    Contrib Nephrol; 1980; 18():147-51. PubMed ID: 7353373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.